Skip to main content
OpenTrials
Completed

NCT Number: NCT01931410

The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial

The investigators hypothesis in this study is that administration of rectal and sublingual misoprostol decreases intrapartum and postpartum haemorrhage.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

ıntrapartum Haemorrhage Female Urogenital Diseases and Pregnancy Complications Hemorrhage Obstetric Labor Complications Pathologic Processes Pathological Conditions, Signs and Symptoms Postpartum Haemorrhage Postpartum Hemorrhage Pregnancy Complications Puerperal Disorders Urogenital Diseases Uterine Hemorrhage

Age range

18 year–44 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • live and singleton pregnancy
  • Elective caesarean
  • Gestational week greater than 37 weeks
  • patient between 18-44 year old

Exclusion criteria

  • -multiple pregnancy
  • Preeclampsia
  • Gestational diabetes
  • Macrosomia
  • Oligohidraamnıos
  • Polihidraamnıos
  • Myoma
  • Morbid obesity
  • Coagulatıon defect (such as HELLP syndrome)

Treatment and study plan

Misoprostol

Drug

Primary outcomes

  1. Postpartum Haemorrhage

    Time frame: postpartum 24 hour

Sponsors and collaborators

Lead sponsor

Istanbul Bakirkoy Maternity and Children Diseases Hospital

Other Gov

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Aug 29, 2013
Registry last updated
Feb 25, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.